Study: Hormone tablet slows prostate cancer’s growth

<p>CHICAGO (AP) — A hormone-blocking tablet authorized final year for some organisation with modernized <span>prostate cancer</span> now also seems to assistance a wider organisation of organisation who were given it progressing in a march of treating their disease.</p>
<p>In a investigate of scarcely 1,100 such men, <span>Johnson Johnson</span>‘s <span>Zytiga</span> doubled a time patients lived nonetheless their <span>cancer</span> removing worse.</p>
<p>The drug also seems to be improving survival, nonetheless it will take longer follow-up to know for sure. Independent monitors stopped a investigate once it was transparent a drug was assisting and let organisation who had been removing manikin pills to switch to Zytiga. At that indicate — after a median diagnosis time of dual years — 34 percent of organisation on manikin pills had died contra 27 percent of those holding Zytiga.</p>
<p>“Our wis...